• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物洗脱球囊治疗颈动脉支架置入术后复发性狭窄:单中心回顾性分析

Recurrent stenosis following carotid artery stenting treated with a drug-eluting balloon: a single-center retrospective analysis.

作者信息

Pohlmann C, Höltje J, Zeile M, Bonk F, Urban P P, Brüning R

机构信息

Abteilung für Neurologie, Asklepios Klinik Barmbek, 22291, Hamburg, Germany.

Radiologie und Neuroradiologie, Asklepios Klinik Wandsbek, 22043, Hamburg, Germany.

出版信息

Neuroradiology. 2018 Jan;60(1):81-87. doi: 10.1007/s00234-017-1935-7. Epub 2017 Oct 20.

DOI:10.1007/s00234-017-1935-7
PMID:29058047
Abstract

PURPOSE

Early in-stent restenosis after stent-protected angioplasty of the carotid artery (SPAC) is an infrequent, but potentially harmful condition for patients with carotid artery disease.

METHODS

In our retrospective single-center analysis of 176 patients with carotid artery stenting between 2009 and 2015, using duplex ultrasound, we detected 9 patients with high-grade carotid artery in-stent restenosis. All restenosis patients were treated with a drug-eluting balloon (DEB) to prevent recurrent neointimal hyperplasia. One patient had bilateral carotid artery disease with bilateral in-stent restenosis, and 1 patient needed repeated DEB treatment 19 months after the first DEB intervention, so 11 DEB procedures, in total, were performed.

RESULTS

The median time-interval between primary carotid artery stenting and first DEB-treatment was 9 months. In 3 of the 11 interventions, the DEB treatment was assisted by an additional stent. One repeat DEB treatment was necessary, and three DEB treatments were followed by a secondary stent. No peri-interventional complications (TIA, stroke, or death) were observed during or after DEB intervention. Therefore, in the entire group, the 1y event-free survival (EFS) was 100%, and the 2y/3y/5y EFS was 83%.

CONCLUSION

DEB intervention seems to be an effective and safe treatment for patients with high-grade in-stent restenosis after SPAC.

摘要

目的

颈动脉支架保护血管成形术(SPAC)后早期支架内再狭窄虽不常见,但对颈动脉疾病患者可能有害。

方法

在我们对2009年至2015年间176例行颈动脉支架置入术患者的回顾性单中心分析中,通过双功超声检测到9例颈动脉支架内高度再狭窄患者。所有再狭窄患者均接受药物洗脱球囊(DEB)治疗以预防复发性内膜增生。1例患者患有双侧颈动脉疾病且双侧支架内再狭窄,1例患者在首次DEB干预后19个月需要重复DEB治疗,因此共进行了11次DEB手术。

结果

初次颈动脉支架置入术与首次DEB治疗之间的中位时间间隔为9个月。在11次干预中的3次中,DEB治疗由额外的支架辅助。需要1次重复DEB治疗,3次DEB治疗后植入了二级支架。在DEB干预期间或之后未观察到围手术期并发症(短暂性脑缺血发作、中风或死亡)。因此,在整个组中,1年无事件生存率(EFS)为100%,2年/3年/5年EFS为83%。

结论

DEB干预似乎是SPAC后支架内高度再狭窄患者的一种有效且安全的治疗方法。

相似文献

1
Recurrent stenosis following carotid artery stenting treated with a drug-eluting balloon: a single-center retrospective analysis.药物洗脱球囊治疗颈动脉支架置入术后复发性狭窄:单中心回顾性分析
Neuroradiology. 2018 Jan;60(1):81-87. doi: 10.1007/s00234-017-1935-7. Epub 2017 Oct 20.
2
Long-term results of drug-eluting balloon angioplasty for treatment of refractory recurrent carotid in-stent restenosis.药物洗脱球囊血管成形术治疗难治性复发性颈动脉支架内再狭窄的长期结果
J Endovasc Ther. 2014 Oct;21(5):671-7. doi: 10.1583/14-4715MR.1.
3
Drug-eluting balloon for treatment of in-stent restenosis after carotid artery stenting: preliminary report.药物洗脱球囊治疗颈动脉支架置入术后支架内再狭窄:初步报告。
J Endovasc Ther. 2012 Dec;19(6):734-42. doi: 10.1583/JEVT-12-4042R.1.
4
Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.紫杉醇洗脱球囊与标准球囊血管成形术治疗股浅动脉和腘动脉支架内再狭窄:PACUBA 试验 1 年结果。
JACC Cardiovasc Interv. 2016 Jul 11;9(13):1386-92. doi: 10.1016/j.jcin.2016.04.012.
5
Zotarolimus-eluting stent for the treatment of recurrent, severe carotid artery in-stent stenosis in the TARGET-CAS population.西罗莫司药物洗脱支架治疗 TARGET-CAS 人群中复发性、严重颈动脉支架内再狭窄
J Endovasc Ther. 2012 Jun;19(3):316-24. doi: 10.1583/11-3805R.1.
6
Management of in-sent restenosis after carotid artery stenting in high-risk patients.高危患者颈动脉支架置入术后支架内再狭窄的管理。
J Vasc Surg. 2006 Feb;43(2):305-12. doi: 10.1016/j.jvs.2005.10.040.
7
Treatment and Predictors of Recurrent Internal Carotid Artery In-Stent Restenosis.治疗及复发性颈内动脉支架内再狭窄的预测因素。
Vasc Endovascular Surg. 2021 May;55(4):374-381. doi: 10.1177/1538574421993716. Epub 2021 Feb 10.
8
Drug-coated balloon dilation before carotid artery stenting of post-carotid endarterectomy restenosis.颈动脉内膜剥脱术后再狭窄患者在颈动脉支架置入术前进行药物涂层球囊扩张。
J Endovasc Ther. 2015 Apr;22(2):212-6. doi: 10.1177/1526602815573498.
9
Percutaneous transluminal angioplasty and stent placement for recurrent carotid artery stenosis.经皮腔内血管成形术及支架置入术治疗复发性颈动脉狭窄
J Neurosurg. 1999 Apr;90(4):688-94. doi: 10.3171/jns.1999.90.4.0688.
10
A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial.药物洗脱球囊联合裸金属支架与裸金属支架与药物洗脱支架治疗分叉病变的单支架技术的多中心随机对照比较:分叉病变中药物洗脱球囊的 6 个月血管造影和 12 个月临床结果研究。
Catheter Cardiovasc Interv. 2012 Dec 1;80(7):1138-46. doi: 10.1002/ccd.23499. Epub 2012 Mar 15.

引用本文的文献

1
Drug-coated Balloons in the Neurovascular Setting: A Comprehensive, Systematic Review of Current Use and Indications.神经血管领域中的药物涂层球囊:当前应用与适应症的全面系统综述
Rev Cardiovasc Med. 2022 Apr 2;23(4):128. doi: 10.31083/j.rcm2304128. eCollection 2022 Apr.
2
Optical coherence tomography findings of balloon angioplasty/stenting for in-stent restenosis after carotid artery stenting.颈动脉支架置入术后支架内再狭窄的球囊血管成形术/支架置入术的光学相干断层扫描结果
Interv Neuroradiol. 2024 Feb 12:15910199241232465. doi: 10.1177/15910199241232465.
3
Drug-Coated Balloons for Treatment of Internal Carotid Artery Restenosis After Stenting: A Single-Center Mid-Term Outcome Study.

本文引用的文献

1
Technical options for treatment of in-stent restenosis after carotid artery stenting.颈动脉支架置入术后支架内再狭窄的治疗技术选择。
J Vasc Surg. 2016 Nov;64(5):1486-1496. doi: 10.1016/j.jvs.2016.07.106.
2
Anatomical and Technical Factors Influence the Rate of In-Stent Restenosis following Carotid Artery Stenting for the Treatment of Post-Carotid Endarterectomy Stenosis.解剖学和技术因素影响颈动脉内膜切除术后狭窄行颈动脉支架置入术后支架内再狭窄的发生率。
PLoS One. 2016 Sep 9;11(9):e0161716. doi: 10.1371/journal.pone.0161716. eCollection 2016.
3
Long-Term Results of Stenting versus Endarterectomy for Carotid-Artery Stenosis.
药物涂层球囊治疗支架内颈内动脉再狭窄:单中心中期结果研究。
Cardiovasc Intervent Radiol. 2024 Mar;47(3):291-298. doi: 10.1007/s00270-024-03663-7. Epub 2024 Feb 7.
4
A retrospective study of drug-coated balloon angioplasty for vertebral artery origin stenosis.药物涂层球囊血管成形术治疗椎动脉起始部狭窄的回顾性研究。
Neuroradiology. 2022 Aug;64(8):1617-1625. doi: 10.1007/s00234-022-02926-9. Epub 2022 Mar 8.
5
Treatment of the Carotid In-stent Restenosis: A Systematic Review.颈动脉支架置入术后再狭窄的治疗:一项系统评价。
Front Neurol. 2021 Oct 4;12:748304. doi: 10.3389/fneur.2021.748304. eCollection 2021.
6
The management of carotid restenosis: a comprehensive review.颈动脉再狭窄的管理:一项全面综述。
Ann Transl Med. 2020 Oct;8(19):1272. doi: 10.21037/atm-20-963.
7
Risk Factors for Recurrent Carotid-Artery Stenosis Following Stenting Treatment.支架治疗后颈动脉再狭窄的危险因素。
Med Sci Monit. 2019 Apr 3;25:2429-2434. doi: 10.12659/MSM.913894.
颈动脉狭窄支架置入术与动脉内膜切除术的长期结果
N Engl J Med. 2016 Mar 17;374(11):1021-31. doi: 10.1056/NEJMoa1505215. Epub 2016 Feb 18.
4
Long-term results of drug-eluting balloon angioplasty for treatment of refractory recurrent carotid in-stent restenosis.药物洗脱球囊血管成形术治疗难治性复发性颈动脉支架内再狭窄的长期结果
J Endovasc Ther. 2014 Oct;21(5):671-7. doi: 10.1583/14-4715MR.1.
5
Drug-eluting balloon for treatment of in-stent restenosis after carotid artery stenting: preliminary report.药物洗脱球囊治疗颈动脉支架置入术后支架内再狭窄:初步报告。
J Endovasc Ther. 2012 Dec;19(6):734-42. doi: 10.1583/JEVT-12-4042R.1.
6
Restenosis after carotid artery stenting and endarterectomy: a secondary analysis of CREST, a randomised controlled trial.颈动脉支架置入术和内膜切除术治疗后再狭窄:CREST 随机对照试验的二次分析。
Lancet Neurol. 2012 Sep;11(9):755-63. doi: 10.1016/S1474-4422(12)70159-X. Epub 2012 Aug 2.
7
Clinical impact and predictors of carotid artery in-stent restenosis.颈动脉支架内再狭窄的临床影响和预测因素。
J Neurol. 2012 Sep;259(9):1896-902. doi: 10.1007/s00415-012-6436-3. Epub 2012 Feb 9.
8
The incidence of carotid in-stent stenosis is underestimated: should it be treated or left alone?颈动脉支架置入术后狭窄的发生率被低估了:应该对其进行治疗还是任其发展?
J Endovasc Ther. 2011 Oct;18(5):726-8. doi: 10.1583/11-3535C.1.
9
Neurovascular in-stent stenoses: treatment with conventional and drug-eluting balloons.神经血管内支架狭窄:使用传统和药物洗脱球囊进行治疗。
AJNR Am J Neuroradiol. 2011 Nov-Dec;32(10):1942-7. doi: 10.3174/ajnr.A2644. Epub 2011 Sep 1.
10
Therapeutic options for carotid in-stent restenosis: review of the literature.颈动脉支架内再狭窄的治疗选择:文献回顾。
J Vasc Interv Radiol. 2010 Oct;21(10):1471-7. doi: 10.1016/j.jvir.2010.06.010.